|
US4873192A
(en)
|
1987-02-17 |
1989-10-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Process for site specific mutagenesis without phenotypic selection
|
|
NZ227684A
(en)
|
1988-01-30 |
1991-07-26 |
Merck Sharp & Dohme |
Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions
|
|
GB9005737D0
(en)
|
1990-03-14 |
1990-05-09 |
Beecham Group Plc |
Novel compounds
|
|
FR2676444B1
(fr)
|
1991-05-16 |
1995-03-10 |
Sanofi Elf |
Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
|
|
EP1191097A1
(en)
|
2000-09-21 |
2002-03-27 |
Leids Universitair Medisch Centrum |
Induction of exon skipping in eukaryotic cells
|
|
US20030105320A1
(en)
|
2001-08-31 |
2003-06-05 |
Becker Michael M. |
Affinity-shifted probes for quantifying analyte polynucleotides
|
|
US7135484B2
(en)
|
2002-08-14 |
2006-11-14 |
Abbott Laboratories |
Azabicyclic compounds are central nervous system active agents
|
|
ATE353899T1
(de)
|
2002-09-30 |
2007-03-15 |
Neurosearch As |
Neue 1,4-diazabicycloalkanderivate, deren herstellung und verwendung
|
|
US8014953B2
(en)
|
2003-08-08 |
2011-09-06 |
The Regents Of The University Of California |
RNA surveillance among curated proteins
|
|
US7399765B2
(en)
|
2003-09-19 |
2008-07-15 |
Abbott Laboratories |
Substituted diazabicycloalkane derivatives
|
|
US7655657B2
(en)
|
2003-12-22 |
2010-02-02 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US7160876B2
(en)
|
2003-12-22 |
2007-01-09 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US7309699B2
(en)
|
2003-12-22 |
2007-12-18 |
Abbott Laboratories |
3-Quinuclidinyl amino-substituted biaryl derivatives
|
|
US7309487B2
(en)
|
2004-02-09 |
2007-12-18 |
George Inana |
Methods and compositions for detecting and treating retinal diseases
|
|
PE20060437A1
(es)
|
2004-06-18 |
2006-06-08 |
Novartis Ag |
COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
|
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
|
CN101223166B
(zh)
|
2004-10-07 |
2011-10-19 |
默沙东公司 |
噻唑基mglur5拮抗剂及其应用方法
|
|
CN101389335A
(zh)
|
2004-10-18 |
2009-03-18 |
安姆根有限公司 |
噻二唑化合物和使用方法
|
|
US7838657B2
(en)
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
|
CN101146796A
(zh)
|
2005-01-26 |
2008-03-19 |
先灵公司 |
作为蛋白激酶抑制剂用于治疗癌症的3-(吲唑-5-基)-(1,2,4)三嗪衍生物及相关化合物
|
|
AR053712A1
(es)
|
2005-04-18 |
2007-05-16 |
Neurogen Corp |
Heteroarilos sustituidos, antagonistas de cb1 (receptor 1 canabinoide)
|
|
US7598052B2
(en)
|
2005-10-11 |
2009-10-06 |
The Regents Of The University Of Michigan |
Expression profile of thyroid cancer
|
|
US8603457B2
(en)
|
2005-12-02 |
2013-12-10 |
University Of Rochester |
Nonsense suppression and genetic codon alteration by targeted modification
|
|
US7834178B2
(en)
|
2006-03-01 |
2010-11-16 |
Bristol-Myers Squibb Company |
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
|
|
RS52062B
(sr)
|
2006-05-19 |
2012-06-30 |
Abbott Laboratories |
Cns aktivni azabiciklični alkanski derivati koji su supstituisani spojenim bicikloheterociklom
|
|
ATE463497T1
(de)
|
2006-05-30 |
2010-04-15 |
Neurosearch As |
Neues 1,4-diaza-bicycloä3.2.2ünonyl-oxadiazolyl- derivat und seine medizinische verwendung
|
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
US8343941B2
(en)
|
2007-03-30 |
2013-01-01 |
Rutgers, The State University Of New Jersey |
Compositions and methods for gene silencing
|
|
US8283116B1
(en)
|
2007-06-22 |
2012-10-09 |
Ptc Therapeutics, Inc. |
Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
|
|
DE102007032507A1
(de)
*
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
EP2203173B1
(en)
|
2007-10-26 |
2015-12-23 |
Academisch Ziekenhuis Leiden |
Means and methods for counteracting muscle disorders
|
|
US7902222B2
(en)
|
2007-11-21 |
2011-03-08 |
Abbott Laboratories |
Biaryl substituted azabicyclic alkane derivatives
|
|
JP5177219B2
(ja)
|
2008-03-18 |
2013-04-03 |
コニカミノルタホールディングス株式会社 |
電気化学的表示素子
|
|
WO2009151546A2
(en)
|
2008-05-27 |
2009-12-17 |
Ptc Therapeutics, Inc. |
Methods for treating spinal muscular atrophy
|
|
US8133724B2
(en)
|
2008-09-17 |
2012-03-13 |
University Of Maryland, Baltimore |
Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
|
|
WO2010075376A2
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2408919B1
(en)
|
2009-03-16 |
2017-10-18 |
CuRNA, Inc. |
Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
|
|
JP2012523225A
(ja)
|
2009-04-10 |
2012-10-04 |
アソシアシオン・アンスティテュ・ドゥ・ミオロジー |
疾患の処置のためのトリシクロ−ｄｎａアンチセンスオリゴヌクレオチド、組成物及び方法
|
|
CN115227709A
(zh)
|
2009-06-17 |
2022-10-25 |
冷泉港实验室 |
用于在对象中调节smn2剪接的组合物和方法
|
|
JO3250B1
(ar)
|
2009-09-22 |
2018-09-16 |
Novartis Ag |
إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
|
|
EP2305679A1
(en)
|
2009-09-28 |
2011-04-06 |
GenKyoTex SA |
Pyrazoline dione derivatives as nadph oxidase inhibitors
|
|
AR079724A1
(es)
*
|
2010-01-20 |
2012-02-15 |
Abbott Lab |
Metodos para el tratamiento del dolor
|
|
DK2531492T3
(en)
|
2010-02-05 |
2016-07-04 |
Heptares Therapeutics Ltd |
1,2,4-triazin-4-amine derivatives
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
US8802642B2
(en)
|
2010-04-28 |
2014-08-12 |
Iowa State University Research Foundation, Inc. |
Spinal muscular atrophy treatment via targeting SMN2 catalytic core
|
|
EP2585455B1
(en)
|
2010-06-24 |
2019-08-07 |
The Regents of the University of California |
Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
|
|
KR101764952B1
(ko)
|
2010-07-29 |
2017-08-03 |
리겔 파마슈티칼스, 인크. |
Ａｍｐｋ-활성화 헤테로시클릭 화합물 및 그의 사용 방법
|
|
JP6625792B2
(ja)
|
2011-03-14 |
2019-12-25 |
エヌエスイー プロダクツ インコーポレイテッド |
細胞浄化を促進するための経口製剤
|
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
US9447075B2
(en)
|
2011-08-02 |
2016-09-20 |
The Brigham And Women's Hospital, Inc. |
Pyridazine derivatives as EAAT2 activators
|
|
EP2771069A4
(en)
|
2011-10-27 |
2015-08-26 |
Mayo Foundation |
INHIBITION OF G-PROTEIN-COUPLED RECEPTOR-6-KINASE POLYPEPTIDE
|
|
JP6193881B2
(ja)
|
2011-12-30 |
2017-09-06 |
ピーティーシー セラピューティクス， インコーポレイテッド |
脊髄性筋萎縮症を治療するための化合物
|
|
CA2862084C
(en)
|
2012-01-26 |
2021-05-11 |
Ptc Therapeutics, Inc. |
1h-isochromen-1-one derivatives and compositions thereof for treating spinal muscular atrophy
|
|
WO2013117693A1
(en)
|
2012-02-10 |
2013-08-15 |
Glaxosmithkline Intellectual Property Development Limited |
Pde4 inhibitor for treating huntington's disease
|
|
ES2697174T3
(es)
|
2012-02-10 |
2019-01-22 |
Ptc Therapeutics Inc |
Compuestos para tratar atrofia muscular espinal
|
|
KR102099997B1
(ko)
|
2012-03-01 |
2020-04-13 |
피티씨 테라퓨틱스, 인크. |
척수성 근위축증을 치료하기 위한 화합물
|
|
US9914722B2
(en)
|
2012-03-23 |
2018-03-13 |
Ptc Therapeutics, Inc. |
Compounds for treating spinal muscular atrophy
|
|
US8729263B2
(en)
*
|
2012-08-13 |
2014-05-20 |
Novartis Ag |
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
|
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
|
US9963699B2
(en)
|
2012-10-15 |
2018-05-08 |
Ionis Pharmaceuticals, Inc. |
Methods for modulating C9ORF72 expression
|
|
KR101879919B1
(ko)
*
|
2013-01-15 |
2018-07-18 |
노파르티스 아게 |
알파 7 니코틴성 아세틸콜린 수용체 작용물질의 용도
|
|
CA2898043C
(en)
*
|
2013-01-15 |
2019-08-06 |
Novartis Ag |
Use of alpha 7 nicotinic receptor agonists for the treatment of narcolepsy
|
|
EP2945633B1
(en)
*
|
2013-01-15 |
2021-06-30 |
Novartis AG |
Use of alpha 7 nicotinic acetylcholine receptor agonists
|
|
ITMI20130063A1
(it)
*
|
2013-01-17 |
2014-07-18 |
Valier Alberto |
Dispositivo manuale per la raccolta dal suolo di frutti o altri oggetti
|
|
US9040712B2
(en)
|
2013-01-23 |
2015-05-26 |
Novartis Ag |
Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
|
|
AR096684A1
(es)
|
2013-06-25 |
2016-01-27 |
Ptc Therapeutics Inc |
Compuestos para tratar atrofia muscular espinal
|
|
KR102318727B1
(ko)
|
2013-07-31 |
2021-10-28 |
노파르티스 아게 |
1,4-이치환된 피리다진 유사체 및 smn-결핍-관련 상태를 치료하기 위한 그의 용도
|
|
CN105392790B
(zh)
|
2013-08-19 |
2019-04-19 |
豪夫迈·罗氏有限公司 |
4H-吡啶并[1,2-a]嘧啶-4-酮化合物制备用于预防或治疗癌症的药物的用途
|
|
CA2922567A1
(en)
|
2013-08-26 |
2015-03-05 |
Purdue Pharma L.P. |
Azaspiro[4.5]decane derivatives and use thereof
|
|
EP3052654A4
(en)
|
2013-09-30 |
2017-05-03 |
The Regents of the University of California |
Identification of structurally similar small molecules that enhance therapeutic exon skipping
|
|
US11162096B2
(en)
|
2013-10-14 |
2021-11-02 |
Ionis Pharmaceuticals, Inc |
Methods for modulating expression of C9ORF72 antisense transcript
|
|
WO2015136947A1
(en)
|
2014-03-14 |
2015-09-17 |
Raqualia Pharma Inc. |
Azaspiro derivatives as trpm8 antagonists
|
|
WO2015143245A1
(en)
|
2014-03-19 |
2015-09-24 |
Isis Pharmaceuticals, Inc. |
Methods for modulating ataxin 2 expression
|
|
US10724092B2
(en)
|
2014-06-10 |
2020-07-28 |
Erasmus University Medical Center Rotterdam |
Methods for characterizing alternatively or aberrantly spliced mRNA isoforms
|
|
GB201410693D0
(en)
|
2014-06-16 |
2014-07-30 |
Univ Southampton |
Splicing modulation
|
|
WO2016027168A2
(en)
*
|
2014-08-20 |
2016-02-25 |
Lifesplice Pharma Llc |
Splice modulating oligonucleotides and methods of use thereof
|
|
US20170355956A1
(en)
|
2014-09-04 |
2017-12-14 |
Rutgers, The State University Of New Jersey |
Compositions for increasing survival of motor neuron protein (smn) levels in target cells and methods of use thereof for the treatment of spinal muscular atrophy
|
|
WO2016064895A1
(en)
|
2014-10-20 |
2016-04-28 |
The Brigham And Women's Hospital, Inc. |
Targeting apolipoprotein e (apoe) in neurologic disease
|
|
US10053697B1
(en)
|
2015-01-09 |
2018-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Programmable alternative splicing devices and uses thereof
|
|
EP3247701B1
(en)
|
2015-01-20 |
2021-09-22 |
Boehringer Ingelheim Animal Health USA Inc. |
Anthelmintic compounds, compositions and method of using thereof
|
|
EP3053577A1
(en)
|
2015-02-09 |
2016-08-10 |
F. Hoffmann-La Roche AG |
Compounds for the treatment of cancer
|
|
WO2016128343A1
(en)
|
2015-02-09 |
2016-08-18 |
F. Hoffmann-La Roche Ag |
Compounds for the treatment of cancer
|
|
US10668171B2
(en)
*
|
2015-05-30 |
2020-06-02 |
Ptc Therapeutics, Inc. |
Methods for modulating RNA splicing
|
|
CN107922396B
(zh)
|
2015-07-20 |
2022-08-05 |
建新公司 |
集落刺激因子-1受体(csf-1r)抑制剂
|
|
US20180271803A1
(en)
|
2015-09-02 |
2018-09-27 |
Pathways Bioscience, Llc |
Compositions and methods for treatment or prevention of oral mucositis
|
|
RU2018112749A
(ru)
|
2015-09-24 |
2019-10-24 |
ГлаксоСмитКлайн Интеллекчуал Проперти (N 2) Лимитед |
Модуляторы индоламин-2,3-диоксигеназы
|
|
US11413278B2
(en)
|
2015-10-08 |
2022-08-16 |
The Regents Of The University Of California |
Compounds and methods for promoting stress resistance
|
|
AU2016334804B2
(en)
|
2015-10-09 |
2022-03-31 |
University Of Southampton |
Modulation of gene expression and screening for deregulated protein expression
|
|
AU2016353961B2
(en)
|
2015-11-12 |
2019-08-29 |
F. Hoffmann-La Roche Ag |
Compositions for treating spinal muscular atrophy
|
|
US20180344680A1
(en)
|
2015-12-08 |
2018-12-06 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for treatment, amelioration, and prevention of diabetes-related skin ulcers
|
|
KR20220100719A
(ko)
|
2015-12-10 |
2022-07-15 |
피티씨 테라퓨틱스, 인크. |
헌팅턴병 치료 또는 개선을 위한 조성물
|
|
US11096956B2
(en)
|
2015-12-14 |
2021-08-24 |
Stoke Therapeutics, Inc. |
Antisense oligomers and uses thereof
|
|
WO2017112954A1
(en)
|
2015-12-23 |
2017-06-29 |
Moonshot Pharma Llc |
Methods for inducing an immune response by promoting premature termination codon read-through
|
|
WO2017123991A1
(en)
|
2016-01-15 |
2017-07-20 |
The Brigham And Women's Hospital, Inc. |
Pyridazine derivatives as eaat2 activators
|
|
JP2019511562A
(ja)
|
2016-02-01 |
2019-04-25 |
アラーキス セラピューティクス， インコーポレイテッド |
Ｒｎａ媒介疾患を処置する化合物および方法
|
|
US9895358B2
(en)
|
2016-02-23 |
2018-02-20 |
Indiana University Research And Technology Corporation |
Combination therapies for treatment of spinal muscular atrophy
|
|
US11674952B2
(en)
|
2016-02-24 |
2023-06-13 |
The Rockefeller University |
Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof
|
|
US11066456B2
(en)
|
2016-02-25 |
2021-07-20 |
Washington University |
Compositions comprising TREM2 and methods of use thereof
|
|
US20170268066A1
(en)
|
2016-03-15 |
2017-09-21 |
Chalmers Ventures Ab |
Cancer biomarkers
|
|
CA3019240A1
(en)
|
2016-03-29 |
2017-10-05 |
Merck Patent Gmbh |
N1-(3,3,3-trifluoro-2-hydroxy-2-methylpropionyl)-piperidine derivatives as inhibitors of pyruvate dehydrogenase kinase
|
|
US10940161B2
(en)
|
2016-04-04 |
2021-03-09 |
University Of Florida Research Foundation, Incorporated |
Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
|
|
EP3442960A1
(en)
|
2016-04-12 |
2019-02-20 |
Esteve Pharmaceuticals, S.A. |
Arylamide derivatives having multimodal activity against pain
|
|
KR20210082548A
(ko)
|
2016-06-13 |
2021-07-05 |
스칼러 락, 인크. |
미오스타틴 억제제의 용도 및 조합 요법
|
|
CN109563515A
(zh)
*
|
2016-07-01 |
2019-04-02 |
阿拉基斯医疗公司 |
化合物和调节rna功能的方法
|
|
CA3043755A1
(en)
|
2016-11-28 |
2018-05-31 |
Ptc Therapeutics, Inc. |
Methods for modulating rna splicing
|
|
EP3583951B1
(en)
|
2017-02-20 |
2026-03-25 |
Kyoto University |
Pharmaceutical composition and treatment method for genetic disease associated with splicing abnormalities
|
|
US11715549B2
(en)
|
2017-05-01 |
2023-08-01 |
Thomas Jefferson University |
Systems-level analysis of 32 TCGA cancers reveals disease-dependent tRNA fragmentation patterns and very selective associations with messenger RNAs and repeat elements
|
|
KR20200017476A
(ko)
*
|
2017-06-14 |
2020-02-18 |
피티씨 테라퓨틱스, 인크. |
Rna 스플라이싱의 변경 방법
|
|
WO2019005993A1
(en)
|
2017-06-28 |
2019-01-03 |
Ptc Therapeutics, Inc. |
METHODS OF TREATING HUNTINGTON'S DISEASE
|
|
CA3067591A1
(en)
|
2017-06-28 |
2019-01-03 |
Ptc Therapeutics, Inc. |
Methods for treating huntington's disease
|
|
KR102636383B1
(ko)
|
2017-08-04 |
2024-02-14 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
US11266640B2
(en)
|
2017-09-20 |
2022-03-08 |
Hangzhou Innogate Pharma Co., Ltd. |
Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor
|
|
SG11202002941WA
(en)
|
2017-10-12 |
2020-04-29 |
Revolution Medicines Inc |
Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
|
|
EP3716767A4
(en)
|
2017-10-24 |
2021-11-24 |
Sangamo Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR TREATMENT OF RARE DISEASES
|
|
EP3479845A1
(en)
|
2017-11-06 |
2019-05-08 |
Stalicla S.A. |
Challenge test for diagnosing subtype of autism spectrum disease
|
|
WO2019094694A1
(en)
|
2017-11-10 |
2019-05-16 |
University Of Massachusetts |
Compositions and methods for the treatment of expanded repeat-associated disorders
|
|
AU2019243048A1
(en)
|
2018-03-27 |
2020-10-15 |
Ptc Therapeutics, Inc. |
Compounds for treating Huntington's disease
|
|
KR20200142039A
(ko)
|
2018-04-10 |
2020-12-21 |
스카이호크 테라퓨틱스, 인코포레이티드 |
암 치료용 화합물
|
|
WO2020005882A1
(en)
|
2018-06-27 |
2020-01-02 |
Ptc Therapeutics, Inc. |
Heteroaryl compounds for treating huntington's disease
|
|
BR112020026534A2
(pt)
|
2018-06-27 |
2021-03-23 |
Ptc Therapeutics, Inc. |
Compostos de heteroarila para o tratamento da doença de huntington
|
|
CA3105174A1
(en)
|
2018-06-27 |
2020-01-02 |
Reborna Biosciences, Inc. |
Prophylactic or therapeutic agent for spinal muscular atrophy
|
|
IL279688B2
(en)
|
2018-06-27 |
2025-01-01 |
Ptc Therapeutics Inc |
Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
|
|
WO2020028814A1
(en)
|
2018-08-03 |
2020-02-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of wee1 kinase
|
|
TW202028183A
(zh)
|
2018-10-10 |
2020-08-01 |
大陸商江蘇豪森藥業集團有限公司 |
含氮雜芳類衍生物調節劑、其製備方法和應用
|
|
US11129829B2
(en)
*
|
2019-06-17 |
2021-09-28 |
Skyhawk Therapeutics, Inc. |
Methods for modulating splicing
|
|
CA3169697A1
(en)
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Thiophenyl derivatives useful for modulating nucleic acid splicing
|
|
JP2023515618A
(ja)
|
2020-02-28 |
2023-04-13 |
リミックス セラピューティクス インコーポレイテッド |
核酸スプライシングを調節するためのピリダジン誘導体
|
|
US20230148184A1
(en)
|
2020-02-28 |
2023-05-11 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20240226098A1
(en)
|
2020-02-28 |
2024-07-11 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20230167093A1
(en)
|
2020-04-08 |
2023-06-01 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
KR20230004575A
(ko)
|
2020-04-08 |
2023-01-06 |
레믹스 테라퓨틱스 인크. |
스플라이싱을 조절하기 위한 화합물 및 방법
|